Purdue Pharma CEO says company considering bankruptcy: Washington Post

  • 📰 Reuters
  • ⏱ Reading Time:
  • 7 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 97%

مصر أخبار أخبار

مصر أحدث الأخبار,مصر عناوين

Purdue Pharma's Chief Executive Officer Craig Landau said the company is co...

FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, U.S., April 25, 2017. REUTERS/George Frey

A Purdue Pharma spokesman told Reuters that the company was looking at all options, but had not yet made a decision.

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

 /  🏆 2. in EG
 

شكرًا لك على تعليقك. سيتم نشر تعليقك بعد مراجعته.

Sure to go down as one of the greatest examples of financial piracy in corporate history. The Sackler Family represent all that is broken in our world today.

Just sell them over the counter

So, nobody seems to think prescribing doctors have anything to do with this horrible addiction problem? So, nobody thinks there SHOULD be powerful pain meds for surgical and cancer reasons, for instance? Good luck surviving w/o if you need it.

Convenient

I always laugh at how many people direct their anger towards Purdue University about this, even though they have nothing to do with Purdue Pharma.

Build a massive fortune by taking advantage of a highly addictive drug, watch tens of thousands spiral into addiction and die, cut and run before the public sphere has an opportunity respond and regulate. The American Dream is alive, people.

Makes sense, they've been morally bankrupt since day one.

مصر أحدث الأخبار, مصر عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Purdue Pharma CEO says bankruptcy is ‘an option’ as company faces opioid lawsuitsCraig Landau told The Washington Post that Purdue is developing a powerful anti-overdose drug in a pro-bono effort to combat the effects of the opioid crisis. Americans paid less for prescriptions in 2018 FDA's improved efficiency in approving generics has shortened the drug approval process. All thanks to Trump's drug pricing strategy.
مصدر: washingtonpost - 🏆 95. / 72 اقرأ أكثر »